Skip to main content
. 2020 Jun 29;7(5):2561–2571. doi: 10.1002/ehf2.12832

TABLE 1.

Baseline characteristics of patients with resistant hypertension randomized to nephron blockade or renin‐angiotensin system blockade group and complete BNP evaluation

n = 140 NBD group n = 73 RASB group n = 67 P
Age (years) 55.8 ± 10 53.7 ± 10.3 0.233
Men, n (%) 54 (74) 53 (79) 0.475
BMI (kg/m2) 30.0 ± 4.9 28.3 ± 3.8 0.031
Obesity (BMI > 30 kg/m2), n (%) 32 (44) 24(36) 0.334
Diabetes mellitus, n (%) 12 (15) 15 (22) 0.609
Dyslipidemia, n (%) 46 (63) 40 (60) 0.326
Duration of hypertension (years) 14.3 ± 10.3 12.7 ± 10.6 0.352
Daytime ambulatory SBP (mmHg) 148.7 ± 12.4 149.9 ± 12.1 0.569
Daytime ambulatory DBP (mmHg) 91.4 ± 10.1 93.3 ± 9.3 0.245
Daytime ambulatory PP (mmHg) 57.4 ± 10.6 56.6 ± 11.2 0.694
Daytime ambulatory HR (bpm) 79.6 ± 9.9 81.7 ± 10.2 0.375
Night‐time ambulatory SBP (mmHg) 137.2 ± 13.1 135.4 ± 13.5 0.419
Night‐time ambulatory DBP (mmHg) 81.0 ± 9.9 80.9 ± 9.5 0.941
Night‐time ambulatory HR (bpm) 70.3 ± 8.8 69 ± 9.9 0.446
Night‐time ambulatory PP (mmHg) 56.2 ± 10.2 54.5 ± 10.5 0.332
Pulse wave velocity (m/s) 10.9 ± 2.1 10.9 ± 1.9 0.949

BMI, body mass index; DBP, diastolic blood pressure; PP, pulse pressure; SBP, systolic blood pressure.

Results are mean ± SD or mediane [IQR].